Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
CNBC Top News ·
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. …
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. Novo Nordisk on Sunday announced that prescriptions of the Wegovy pill have topped 3 million since it entered the U.S. market about five months ago. …
Original source: CNBC Top News
Mentioned
Danish · Wegovy · Zepbound · Foundayo · Eli Lilly · New Orleans · Novo Nordisk